Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
During this absorption window, blood flow to the injection site directly affects how much peptide reaches systemic circulation and how much remains concentrated locally
Human evidence is absent: every in-vivo study published to date is rodent, and no NNMT inhibitor is approved anywhere
Any active skincare product can cause sensitivity in some people
If skin/connective-tissue research is the focus, GLOW adds GHK-Cu
